Abstract
Background
Syphilis in pregnancy and congenital syphilis are growing public health issues worldwide. Several factors can influence their occurrence in the population. Therefore, understanding the epidemiology of this condition and the factors that influence its occurrence is fundamental for decision-making by clinicians and health managers. However, so far, no systematic review has summarized and analyzed data on the incidence, prevalence, and predictors of these diseases in Brazilian cities, considering different sociocultural, demographic, economic, sanitary, and spatial-temporal characteristics presented across locations.
Objective
We propose a systematic review protocol to gather and analyze data on the incidence, prevalence, and risk or associated factors of syphilis in pregnancy and congenital syphilis in Brazil, taking into account different local or regional contexts.
Methods
Searches will be conducted in CINAHL, MEDLINE, LILACS, Embase, and Web of Science databases. We will include observational studies (ie, cross-sectional, longitudinal, or case-control studies), analyzing the incidence, prevalence, and risk or associated factors of syphilis in pregnancy and congenital syphilis in Brazil from primary data. The diagnosed syphilis will be assessed based on direct pathogen detection tests or through immunological, treponemal or nontreponemal tests, following Brazilian protocols for diagnosing syphilis. The studies are currently undergoing screening in the databases, and after this step, 2 reviewers will perform all identified documents. The Newcastle-Ottawa Scale and the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) system will be used to assess methodological quality and quality of evidence of studies, respectively. The Kappa coefficient will assess the agreement between researchers in each study stage. Cochran Q test will assess the heterogeneity among studies. Then, a random-effects meta-analysis will be performed.
Results
Results will be discussed based on subgroup analysis, which is as follows: (1) type of syphilis (in pregnancy or congenital), (2) type of study (case-control and cross-sectional studies for analysis of associated factors and longitudinal studies for risk factors), and (3) contextual factors (ie, region of country, socioeconomic and demographic characteristics, and year of study). This systematic review is expected to be completed by December 2023, and our results will be disseminated through publication in peer-reviewed journals and scientific events.
Conclusions
This systematic review aims to assist health care managers and professionals in their decision-making to control these diseases in Brazil, considering location heterogeneity. Furthermore, countries with health systems and demographic and socioeconomic contexts similar to those of Brazil may benefit from this information.
International Registered Report Identifier (IRRID)
DERR1-10.2196/50702
Keywords: sexually transmitted diseases, epidemiology, prevalence, incidence, Brazil, syphilis, pregnancy, sociocultural, economic, congenital syphilis, heterogeneity, decision-making
Introduction
Syphilis is a sexually transmitted infection caused by Treponema pallidum and is a major public health issue worldwide [1]. Despite the efforts of health care professionals to control this infection in Brazil, cases of syphilis have increased in recent years [2-4], impacting public and private health care systems and highlighting the need to improve disease surveillance [5,6]. Globally, 2 million out of 36 million syphilis infections occur in pregnant women [7], resulting in congenital syphilis (infection of the fetus) and adverse events (eg, early fetal death, stillbirth, premature birth, low birth weight, and neonatal death) [8,9].
Recently, an outbreak of syphilis has been observed among men and women in more economically developed countries, which can be explained by changes in the sexual behavior of individuals and increased exposure to the risk of infection due to a false sense of security stemming from new treatments and an increased search for sexual partners over the internet [10]. In this context, understanding the epidemiology and control of this disease becomes more complex and difficult.
Syphilis in pregnancy and congenital syphilis can be controlled with health care measures, such as access to prevention services, early diagnosis, and treatment [4,11,12]. Conversely, these measures require the analysis of epidemiological data and predictors [4,11]. Although studies in Brazilian cities analyzed the incidence, prevalence, and predictors of syphilis in pregnancy and congenital syphilis [13-17], each city presented different sociocultural, demographic, economic, sanitary, and spatial-temporal characteristics, hindering data extrapolation to the national territory.
Summarizing and analyzing the incidence, prevalence, and risk or associated factors of syphilis in pregnancy and congenital syphilis must take into account location heterogeneity. This type of analysis enables a broader understanding of the problem, improves control strategies and equity in disease management, and establishes reference data to help disease screening efforts in Brazil. Despite the relevance of the theme, no systematic review has been conducted to date on the epidemiological data of gestational and congenital syphilis or its predictors, subgrouping and analyzing this information from different contexts.
Thus, we propose a systematic review protocol to gather and analyze data on the incidence, prevalence, and risk or associated factors of syphilis in pregnancy and congenital syphilis in Brazil, taking into account different local or regional contexts.
Methods
Study Design
This systematic review protocol was developed according to PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) [18], which will also guide the systematic review. The protocol has been registered in PROSPERO (CRD42022329329).
Eligibility Criteria
Observational studies whose sample comprised cases of syphilis in pregnant women or newborns in Brazil will be included in the systematic review. Table 1 [2,19,20] presents the eligibility criteria used in the review.
Table 1.
Eligibility criteria for the systematic review.
Variables | Inclusion criteria | Exclusion criteria |
Study design |
|
|
Population and location |
|
|
Outcomes |
|
|
Language | —a |
|
Time frame | — |
|
aNot applicable.
Study Selection
Textbox 1 presents the search strategy. Searches will be conducted in the CINAHL, MEDLINE, LILACS, Embase, and Web of Science databases. Grey literature will be also searched using the reference lists of relevant studies in addition to using databases such as Open Gray and Google Scholar. Further, reports with epidemiological data on syphilis in the country will be screened in the electronic database of the Brazilian Ministry of Health.
Search strategy.
#1 “syphilis” [Title/Abstract] OR “congenital syphilis” [Title/Abstract] OR “treponemal infections” [Title/Abstract] OR “T. pallidum” [Title/Abstract] OR “pallidum” [Title/Abstract] OR “serosyphilis” [Title/Abstract] OR “sexually transmitted diseases” [Title/Abstract]
#2 “pregnant” [Title/Abstract] OR “women” [Title/Abstract] OR “congenital” [Title/Abstract]
#3 “incidence” [Title/Abstract] OR “prevalence” [Title/Abstract] OR “prevalence study” [Title/Abstract] OR “cross-sectional study” [Title/Abstract] OR “observational study” [Title/Abstract]
#4 “risk factors” [Title/Abstract] OR “associated factors” [Title/Abstract] OR “measures of association, exposure, risk or outcome” [Title/Abstract]
#5 “brazil” [Title/Abstract] OR “brazilian” [Title/Abstract]
#6 #1 AND #2 AND #3 OR #4 AND #5
Two researchers will independently search, identify potentially eligible studies, and remove duplicates. Then, inclusion and exclusion criteria will be applied to titles and abstracts, eligible studies will be read in full, and reasons for exclusion will be recorded. Disagreements between researchers will be resolved by discussion or with a third researcher. The flowchart of the study selection is described in Figure 1.
Figure 1.
Flowchart of the study. The numbers are to be confirmed.
Assessment of Methodological Quality and Quality of Evidence
The Newcastle-Ottawa Scale will be used to assess the methodological quality of studies [21]. This scale includes 8 items categorized into 3 domains (ie, selection, comparability, and outcome or exposure) to assess the risk of bias in nonrandomized studies. The Newcastle-Ottawa Scale has specific tools for cohort and case-control studies. Thus, adaptations will be made to allow the proper assessment of the potential sources of bias in cross-sectional studies. In addition, quality of evidence will be analyzed using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) system, which classifies evidence as high, moderate, low, and very low [22,23].
Data Extraction and Synthesis
The following data will be extracted and entered into a Microsoft Excel spreadsheet: first author, year of publication, type of study (eg, longitudinal, cross-sectional, or case-control), type of syphilis (eg, in pregnancy or congenital), the diagnostic method used, study location (eg, city and state), participants (eg, sample size, age, type of population, and presence of co-infection), population setting (eg, community, health care centers, schools, neighborhoods, and the environmental context of the participants), date of data collection, sampling method, and main results (eg, incidence, prevalence, and risk or associated factors).
After summarizing the studies, results will be discussed based on subgroup analysis, as follows: (1) type of syphilis (eg, in pregnancy or congenital), (2) type of study (eg, case-control and cross-sectional for analysis of associated factors and longitudinal for risk factors), and (3) contextual factors (eg, region of country, socioeconomic and demographic characteristics, and year of study).
Statistical Planning
Kappa coefficient will assess the agreement between researchers [24]. The unadjusted incidence or prevalence and the standard error will be recalculated based on the numerator and denominator values presented in each study. Furthermore, the prevalence or incidence may be reported using the direct method of standardization, adjusted for the variables of age, study location, and presence of co-infection. If the study does not provide data for calculating adjusted incidence or prevalence, the researchers will request this information from the study authors.
Additionally, a meta-analysis will be performed using a random-effects model due to the potential heterogeneity among studies. The random-effects model is applied when the aim is to combine several studies that have similar objectives but are conducted in different ways (ie, exhibiting methodological heterogeneity) [25]. Moreover, the Freeman-Tukey double arcsine transformation will stabilize variances to maintain the estimates of individual effects of each study [26]. Cochran Q test will assess the heterogeneity among studies [27]. I2 values of 25%, 50%, and 75% will represent low, medium, and high heterogeneity, respectively [28].
Studies will undergo a subgroup analysis using clustering variables (eg, study location, study population, method of syphilis diagnosis, mean sample size, year of data collection, sampling methods, and methodological quality) to investigate possible sources of heterogeneity [20].
Analyzes will be performed using the Review Manager (RevMan) software (version 5.4; Cochrane Collaboration) and the R software (R Core Team), considering a 95% CI.
Results
The protocol has been registered in PROSPERO (CRD42022329329). The screening of the studies in the databases has already started, and the entire systematic review is expected to be completed by December 2023. The results of the study will provide evidence that can support decision-making regarding strategies to control syphilis in Brazil and countries with similar health, demographic, and socioeconomic profiles. Results will be disseminated through publication in peer-reviewed journals and presentation at scientific events.
Discussion
Expected Results and Practical Implications
After a preliminary search, we found studies in Brazilian cities that analyzed epidemiological data and predictors of syphilis in pregnancy and congenital syphilis [13-17,29]. However, no study has organized and summarized data to perform a broader analysis of this public health issue.
Summarizing local studies will allow the analysis and discussion of epidemiology and risk or associated factors of syphilis in pregnancy and congenital syphilis, considering sociocultural, demographic, spatial-temporal, economic, and sanitary differences in each location. Thus, this systematic review will help in the decision-making of health care managers and professionals to control these diseases in Brazil according to location heterogeneity.
Limitations
Some limitations that may compromise the quality of evidence can be found in the systematic review, such as heterogeneity among studies, wide CIs, and uncertainty of estimated effects.
Acknowledgments
The authors would like to thank Probatus Academic Services for providing scientific language translation and revision.
This study was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil (finance code 001).
Abbreviations
- GRADE
Grading of Recommendations, Assessment, Development, and Evaluations
- PRISMA-P
Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols
Data Availability
All data generated and analyzed in this study are available upon request from the corresponding author.
Footnotes
Authors' Contributions: YTP, JCD, and ANAF designed the study and wrote the original draft; JRRH and RARS designed the study and approved the final manuscript.
Conflicts of Interest: None declared.
References
- 1.Kojima Noah, Klausner J. An update on the global epidemiology of syphilis. Curr Epidemiol Rep. 2018 Mar;5(1):24–38. doi: 10.1007/s40471-018-0138-z. https://europepmc.org/abstract/MED/30116697 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gaspar PC, Bigolin A, Alonso Neto JB, Pereira E, Bazzo M. Brazilian Protocol for Sexually Transmitted Infections 2020: syphilis diagnostic tests. Rev Soc Bras Med Trop. 2021;54(suppl 1):e2020630. doi: 10.1590/0037-8682-630-2020. https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822021000501212&lng=en&nrm=iso&tlng=en .S0037-86822021000501212 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Domingues CSB, Duarte G, Passos M, Sztajnbok DDN, Menezes M. Brazilian Protocol for Sexually Transmitted Infections, 2020: congenital syphilis and child exposed to syphilis. Rev Soc Bras Med Trop. 2021;54(suppl 1):e2020597. doi: 10.1590/0037-8682-597-2020. https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822021000501204&lng=en&nrm=iso&tlng=en .S0037-86822021000501204 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Freitas FLS, Benzaken A, Passos MD, Coelho I, Miranda A. Brazilian Protocol for Sexually Transmitted Infections 2020: acquired syphilis. Rev Soc Bras Med Trop. 2021;54(suppl 1):e2020616. doi: 10.1590/0037-8682-616-2020. https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822021000501210&lng=en&nrm=iso&tlng=en .S0037-86822021000501210 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Brasil. Ministério da Saúde—Departamento de Informática do Sistema Único de Saúde do Brasil. Sífilis em gestante - Casos confirmados notificados no Sistema de Informação de Agravos de Notificação - Brasil. 2021. [2023-12-12]. http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinannet/cnv/sifilisgestantebr.def .
- 6.Ribeiro AF. Concordância dos Dados de Mortalidade por Doenças de Notificação Compulsória no Sistema de Informação sobre Mortalidade- Sim e Sistema de Informação de Agravos de Notificação-SINAN, Brasil 2007 a 2015. RGSS. 2017 Aug 01;6(2):173–183. doi: 10.5585/rgss.v6i2.345. [DOI] [Google Scholar]
- 7.Peeling RW, Mabey D, Kamb M, Chen X, Radolf J, Benzaken A. Syphilis. Nat Rev Dis Primers. 2017 Oct 12;3:17073. doi: 10.1038/nrdp.2017.73. https://europepmc.org/abstract/MED/29022569 .nrdp201773 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Milanez Helaine. Syphilis in pregnancy and congenital syphilis: why can we not yet face this problem? Rev Bras Ginecol Obstet. 2016 Sep;38(9):425–427. doi: 10.1055/s-0036-1593603. http://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1593603 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.D'Aiuto C, Valderrama A, Byrns M, Boucoiran I. Sexually transmitted and blood-borne infections in pregnant women and adverse pregnancy outcomes. J Obstet Gynaecol Can. 2020 Aug;42(8):977–983. doi: 10.1016/j.jogc.2020.01.023. doi: 10.1016/j.jogc.2020.01.023.S1701-2163(20)30102-X [DOI] [PubMed] [Google Scholar]
- 10.Mercuri SR, Moliterni E, Cerullo A, Di Nicola MR, Rizzo N, Bianchi V, Paolino G. Syphilis: a mini review of the history, epidemiology and focus on microbiota. New Microbiol. 2022 Jan;45(1):28–34. http://www.newmicrobiologica.org/PUB/allegati_pdf/2022/1/28.pdf .496N273 [PubMed] [Google Scholar]
- 11.Bezerra MLdMB, Fernandes F, de Oliveira Nunes JP, de Araújo Baltar SLSM, Randau K. Congenital syphilis as a measure of maternal and child healthcare, Brazil. Emerg Infect Dis. 2019 Aug;25(8):1469–1476. doi: 10.3201/eid2508.180298. doi: 10.3201/eid2508.180298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Domingues Csb, Duarte G, Passos M, Sztajnbok DDN, Menezes M. Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: sífilis congênita e criança exposta à sífilis. Epidemiol Serv Saúde. 2021;30(spe1):e2020597. doi: 10.1590/s1679-4974202100005.esp1. doi: 10.1590/s1679-4974202100005.esp1. [DOI] [PubMed] [Google Scholar]
- 13.Neto PLF, Fonseca RDS, Avelino MDS, Vilhena E, Barbosa MDADA, Lopes C, Gomes STM, Sequeira BJ, Laurentino Rogério Valois, Freitas Felipe Bonfim, Oliveira-Filho Aldemir Branco, Machado Luiz Fernando Almeida. Prevalence and factors associated with syphilis in people living with HIV/AIDS in the State of Pará, Northern Brazil. Front Public Health. 2021;9:646663. doi: 10.3389/fpubh.2021.646663. https://europepmc.org/abstract/MED/34434909 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.da Silva Santana R, Kerr L, Mota R, Kendall C, Rutherford G, McFarland W. Lifetime syphilis prevalence and associated risk factors among female prisoners in Brazil. Sexual Trans Dis. 2019 Dec 18;47(2):105–110. doi: 10.1097/OLQ.0000000000001113. doi: 10.1097/OLQ.0000000000001113. [DOI] [PubMed] [Google Scholar]
- 15.Cavalcante PAldM, Pereira RDL, Castro J. Syphilis in pregnancy and congenital syphilis in Palmas, Tocantins State, Brazil, 2007-2014. Epidemiol Serv Saude. 2017;26(2):255–264. doi: 10.5123/S1679-49742017000200003. https://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-96222017000200255&lng=en&nrm=iso&tlng=en .S2237-96222017000200255 [DOI] [PubMed] [Google Scholar]
- 16.Soares Mas, Aquino R. Completude e caracterização dos registros de sífilis gestacional e congênita na Bahia, 2007-2017. Epidemiol Serv Saúde. 2021;30(4):e20201148. doi: 10.1590/s1679-49742021000400018. doi: 10.1590/s1679-49742021000400018. [DOI] [PubMed] [Google Scholar]
- 17.Amorim Ekr, Matozinhos F, Araújo L, Silva Tprd. Tendência dos casos de sífilis gestacional e congênita em Minas Gerais, 2009-2019: um estudo ecológico. Epidemiol Serv Saúde. 2021;30(4):e2021128. doi: 10.1590/s1679-49742021000400006. doi: 10.1590/s1679-49742021000400006. [DOI] [PubMed] [Google Scholar]
- 18.Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015 Jan 02;350(jan02 1):g7647–g7647. doi: 10.1136/bmj.g7647. https://core.ac.uk/reader/33589190?utm_source=linkout . [DOI] [PubMed] [Google Scholar]
- 19.Kitayama en, Segura E, Lake J, Perez-Brumer A, Oldenburg C, Myers B, Pourjavaheri P, Okorie Chinomnso N, Cabello Robinson L, Clark Jesse L. Syphilis in the Americas: a protocol for a systematic review of syphilis prevalence and incidence in four high-risk groups, 1980-2016. Syst Rev. 2017 Oct 10;6(1):195. doi: 10.1186/s13643-017-0595-3. https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-017-0595-3 .10.1186/s13643-017-0595-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kebede KM, Abateneh D, Belay A, Manaye G. The epidemiology of syphilis in Ethiopia: a protocol for systematic review and meta-analysis covering the last three decades. Syst Rev. 2019 Aug 22;8(1):210. doi: 10.1186/s13643-019-1136-z. https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-019-1136-z .10.1186/s13643-019-1136-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. [2023-12-12]. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp .
- 22.Iorio A, Spencer FA, Falavigna M, Alba C, Lang E, Burnand B, McGinn T, Hayden J, Williams K, Shea B, Wolff R, Kujpers T, Perel P, Vandvik PO, Glasziou P, Schunemann H, Guyatt G. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ. 2015 Mar 16;350(mar16 7):h870–h870. doi: 10.1136/bmj.h870. https://core.ac.uk/reader/29151775?utm_source=linkout . [DOI] [PubMed] [Google Scholar]
- 23.Atkins D, Best D, Briss P, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour Robin T, Haugh Margaret C, Henry David, Hill Suzanne, Jaeschke Roman, Leng Gillian, Liberati Alessandro, Magrini Nicola, Mason James, Middleton Philippa, Mrukowicz Jacek, O'Connell Dianne, Oxman Andrew D, Phillips Bob, Schünemann Holger J, Edejer Tessa Tan-Torres, Varonen Helena, Vist Gunn E, Williams John W, Zaza Stephanie. Grading quality of evidence and strength of recommendations. BMJ. 2004 Jun 19;328(7454):1490. doi: 10.1136/bmj.328.7454.1490. https://europepmc.org/abstract/MED/15205295 .328/7454/1490 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hsu Lm, Field R. Interrater Agreement Measures: Comments on Kappa, Cohen's Kappa, Scott's π, and Aickin's α. Understanding Statistics. 2003;2(3):205–219. doi: 10.1207/S15328031US0203_03. doi: 10.1207/S15328031US0203_03. [DOI] [Google Scholar]
- 25.Spineli LM, Pandis N. Meta-analysis: random-effects model. Am J Orthod Dentofacial Orthop. 2020;157(2):280–282. doi: 10.1016/j.ajodo.2019.10.007. doi: 10.1016/j.ajodo.2019.10.007.S0889-5406(19)30858-3 [DOI] [PubMed] [Google Scholar]
- 26.Mansfield KE, Sim J, Jordan J, Jordan K. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population. Pain. 2016;157(1):55–64. doi: 10.1097/j.pain.0000000000000314. https://europepmc.org/abstract/MED/26270591 .00006396-201601000-00006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Cochran William G. The combination of estimates from different experiments. Biometrics. 1954;10:101. doi: 10.2307/3001666. doi: 10.2307/3001666. [DOI] [Google Scholar]
- 28.Higgins JPT, Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 Jun 15;21(11):1539–58. doi: 10.1002/sim.1186. doi: 10.1002/sim.1186. [DOI] [PubMed] [Google Scholar]
- 29.Torres RG, Mendonça ALN, Montes G, Manzan J, Ribeiro J, Paschoini M. Syphilis in pregnancy: the reality in a public hospital. Rev Bras Ginecol Obstet. 2019 Feb;41(2):90–96. doi: 10.1055/s-0038-1676569. http://www.thieme-connect.com/DOI/DOI?10.1055/s-0038-1676569 . [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data generated and analyzed in this study are available upon request from the corresponding author.